About Stelis Biopharma Private Limited
Data last updated:
Stelis Biopharma Private Limited was a private limited company based in Bangalore, Karnataka, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 16 May 2012.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2012PTC063995.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.38 Lakh. It was formerly known as Agila Biotech Private Limited. It was led by directors Sudhir Krishna Kanchan and Joe Thomas Mangalam.
Its last annual general meeting (AGM) was held on 08 September 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office was at Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076.
The company was associated with 3 brands: Stelis Biopharma, Stelis Biosource and Inbiopro. Court records list 2 cases involving the company, including 2 filed by the company.
The last known website on record is inbiopro.com.
Company details
Contact details
Stelis Biopharma Private Limited's registered office is in Bangalore, Karnataka.
- Social Media
- Registered AddressStrideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stelis Biopharma operates multiple associated brands including Stelis Biopharma, Stelis Biosource, and Inbiopro. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract development and manufacturing for drug products globally. | stelis.com | |
| End-to-end biopharmaceutical manufacturing solutions are provided by Stelis Biosource. | stelisbiosource.com | |
| Biosimilars and biological therapeutics are developed in India. | inbiopro.com |
Financials of Stelis Biopharma Private Limited
FY 2014 filings availableFinancial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Stelis Biopharma Private Limited, buy the company report.
Board of directors of Stelis Biopharma Private Limited
Stelis Biopharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Joe Thomas Mangalam | Additional Director | 06 Mar 2014 | 12 Years 7 Months | As last reported |
| Sudhir Krishna Kanchan | Director | 16 May 2012 | 14 Years 5 Months | As last reported |
Legal cases
Stelis Biopharma Private Limited has 2 court cases on record: 2 filed by Stelis Biopharma. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Disposed |
To see the full case history of Stelis Biopharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Stelis Biopharma Private Limited was last rated by Icra on 24 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 24 Mar 2022 |
To see the full credit ratings and regulatory alerts of Stelis Biopharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stelis Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Stelis Biopharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Stelis Biopharma Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Anand Iyer ceased to be Director on 06 Mar 2014.
News
Frequently asked questions
Stelis Biopharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Stelis Biopharma was a private limited company based in Bangalore, Karnataka, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 16 May 2012 and is registered under CIN U24100KA2012PTC063995. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Stelis Biopharma was incorporated on 16 May 2012. It is registered with the Registrar of Companies, Bangalore.
Stelis Biopharma had 2 directors:
- Joe Thomas Mangalam - Additional Director
- Sudhir Krishna Kanchan - Director
The CIN (Corporate Identification Number) of Stelis Biopharma is U24100KA2012PTC063995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Stelis Biopharma is at Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076.
Stelis Biopharma can be reached through the website inbiopro.com. Its registered office is in Bangalore, Karnataka, India.
The latest financial statements of Stelis Biopharma on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 08 September 2014. Year-wise statements from 2015 are in the company report.
Stelis Biopharma operated in the life sciences industry, in the biotechnology segment.
Stelis Biopharma has 2 court cases on record: 2 filed by the company.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
